Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
2.420
-0.340 (-12.32%)
Jul 9, 2026, 2:27 PM EDT - Market open
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $61.03 million as of July 9, 2026. Its market cap has decreased by -81.40% in one year.
Market Cap
61.03M
Enterprise Value
n/a
1-Year Change
-81.40%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $61.03M, a decrease of -80.65%. That is a compound annual growth rate of -60.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 61.03M | -81.91% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 60.87M |
| Context Therapeutics | 58.58M |
| MiNK Therapeutics | 57.59M |
| Xilio Therapeutics | 56.48M |
| Immutep | 56.21M |
| Boundless Bio | 56.16M |
| Instil Bio | 52.36M |
| Impact BioMedical | 51.43M |